|
Epidemiology of myelodysplastic syndromes
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: therapy and outlook
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Why are myelodysplastic syndromes unrecognized and underdiagnosed?: a primary care perspective
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Commentary on "clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
The value of survival gains in myelodysplastic syndromes.
|
Jan 2017
|
Am J Manag Care
|
myelodysplastic syndromes (MDS)
|
|
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria
|
Feb 2012
|
Am J Hum Genet
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes
|
Mar 2017
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Laboratory tests for paroxysmal nocturnal hemoglobinuria (PNH).
|
Oct 2013
|
Am J Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience
|
Aug 2017
|
Am J Hematol
|
aplastic anemia
|
|
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
|
Aug 2012
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
